12 Biggest Mid-Day Gainers For Tuesday - Akari Therapeutics (NASDAQ:AKTX)

Interpace Diagnostics Group Inc IDXG shares climbed 77.2 percent to $3.80. Interpace Diagnostics reported the coverage of ThyraMIR with UnitedHealthcare.
GNC Holdings Inc GNC shares surged 17 percent to $8.47 after the company reported stronger-than-expected results for its first quarter.
Motif Bio plc – ADR MTFB gained 16.4 percent to $8.36 after the company reported positive results for iclaprim, in the REVIVE-1 Phase 3 study.
Microvision, Inc. MVIS shares climbed 15.5 percent to $2.37.
Akari Therapeutics, Plc AKTX shares jumped 12.1 percent to $14.92 after dropping 16.92 percent on Monday.
Cytokinetics, Inc. CYTK shares surged 11.1 percent to $13.05. Cytokinetics will replace Cardinal Financial Corp. CFNL in the S&P SmallCap 600 on Monday, April 24.
Stratasys, Ltd. SSYS rose 11 percent to $23.65. PiperJaffray upgraded Stratasys from Neutral to Overweight.
Core-Mark Holding Company, Inc. CORE shares surged 10.7 percent to $34.06. Raymond James upgraded Core-Mark from Outperform to Strong Buy.
Tile Shop Hldgs, Inc. TTS shares gained 10.3 percent to $21.40 after the company posted upbeat Q1 earnings.
XOMA Corp XOMA rose 8 percent to $7.02 after the company reported the presentation of positive data from its anti-PTH1R antagonist monoclonal antibody program.
Cabelas Inc CAB gained 7.2 percent to $57.55. Cabela's disclosed that it has entered into revised transaction agreements in connection with Bass Pro Shops merger.
Gigamon Inc GIMO shares rose 5.2 percent to $36.12. Gigamon will replace Ixia XXIA in the S&P SmallCap 600 on Thursday, April 20.

Market News and Data brought to you by Benzinga APIs